CelluPro Strengthens Global GMP Supply Assurance with ISO 22301-Certified Business Continuity Management System

CelluPro, a provider of GMP-grade cell culture media solutions for the global biopharmaceutical industry, continues to strengthen its commitment to manufacturing excellence, supply reliability, and sustainable growth through the implementation of an ISO 22301-certified Business Continuity Management System (BCMS).

As the biopharmaceutical industry advances toward more flexible, efficient, and sustainable manufacturing models, reliable access to high-quality raw materials has become increasingly critical. Beyond product performance, biopharmaceutical companies require trusted partners capable of ensuring consistent quality, resilient supply chains, and long-term operational stability.

Through integrated quality management systems, GMP-compliant manufacturing capabilities, and strengthened business continuity practices, CelluPro is enhancing its ability to support global partners throughout the entire bioprocessing lifecycle.

Supporting the Future of Advanced Biomanufacturing

The global biopharmaceutical industry is undergoing significant transformation, driven by increasing demand for biologics, accelerated development timelines, and the growing adoption of advanced manufacturing strategies.

Emerging approaches such as process intensification, high-density cell culture, and continuous bioprocessing are enabling manufacturers to improve productivity, optimize facility utilization, and enhance manufacturing flexibility.

In particular, continuous and intensified upstream processes require highly reliable cell culture systems capable of supporting sustained cell growth, consistent productivity, and robust performance over extended production cycles.

As these next-generation manufacturing approaches continue to evolve, the stability and reliability of critical raw materials — including cell culture media — play an essential role in ensuring successful bioprocess outcomes.

CelluPro is committed to supporting this industry evolution by providing high-performance serum-free cell culture media solutions designed for scalable and reliable biomanufacturing applications.

Enhancing Supply Resilience Through ISO 22301 Business Continuity Management

To further strengthen operational resilience and supply assurance, CelluPro has established an ISO 22301-certified Business Continuity Management System, an internationally recognized framework for managing operational risks and ensuring business continuity.

The ISO 22301 standard provides a structured approach for organizations to identify potential disruptions, develop effective response strategies, and maintain critical operations under changing conditions.

Through this system, CelluPro continuously enhances its capabilities in:

• Risk identification and preventive management
• Emergency response and recovery planning
• Operational resilience improvement
• Continuous evaluation and optimization of business continuity processes

For global biopharmaceutical manufacturers, supply continuity is a key factor influencing production planning and operational success. CelluPro’s ISO 22301 certification reflects its commitment to providing reliable and stable supply support for customers worldwide.

Built on GMP Manufacturing Excellence and International Quality Standards

CelluPro’s supply reliability is supported by advanced manufacturing infrastructure, rigorous quality management systems, and comprehensive process controls.

The company operates GMP-compliant manufacturing facilities designed to ensure consistent product quality, manufacturing reliability, and regulatory readiness.

CelluPro has established management systems aligned with internationally recognized standards, including:

ISO 9001 – Quality Management System

ISO 13485 – Quality Management System for Medical Devices

ISO 14001 – Environmental Management System

ISO 45001 – Occupational Health and Safety Management System

ISO 22301 – Business Continuity Management System

In addition, CelluPro has achieved EXCiPACT™ GMP certification for Pharmaceutical Auxiliary Materials (PAMs), demonstrating its commitment to globally recognized quality requirements for critical pharmaceutical materials.

With advanced manufacturing technologies, comprehensive analytical testing capabilities, and strict quality control processes, CelluPro continues to deliver consistent and reliable cell culture media solutions to support biopharmaceutical development and manufacturing programs.

Enabling Next-Generation Bioprocessing with Advanced Cell Culture Media Solutions

As biopharmaceutical manufacturers increasingly adopt intensified and continuous production strategies, cell culture media performance becomes a critical factor in achieving high productivity and process robustness.

CelluPro provides a comprehensive portfolio of serum-free cell culture media solutions supporting diverse bioprocessing applications, including:

• CHO Cell Culture Solutions

Designed to support recombinant protein production with robust cell growth, high productivity, and scalable manufacturing performance.

• Perfusion Media Solutions

CelluPro’s perfusion media solutions support high-density continuous cultivation processes, enabling sustained cell growth and efficient protein production for intensified biomanufacturing platforms.

• HEK293 and Advanced Therapy Solutions

Supporting applications including recombinant protein expression, viral vector production, and emerging cell and gene therapy workflows.

By combining advanced media development capabilities with reliable manufacturing systems, CelluPro helps biopharmaceutical partners improve process efficiency and accelerate innovation.

Advancing Sustainable Manufacturing Through ESG Commitment

In addition to quality and supply assurance, CelluPro integrates environmental, social, and governance (ESG) principles into its long-term development strategy.

Sustainable manufacturing is becoming increasingly important across the biopharmaceutical industry. Advanced manufacturing approaches, including intensified and continuous processes, provide opportunities to improve resource utilization, enhance operational efficiency, and reduce manufacturing footprint.

CelluPro continues to promote responsible manufacturing practices through:

Environmental Responsibility

• Improving manufacturing efficiency and resource utilization
• Strengthening environmental management practices aligned with ISO 14001 principles
• Continuously optimizing operational processes toward sustainable development

Social Responsibility

• Maintaining a safe and compliant working environment
• Supporting employee development and operational excellence
• Building a culture of quality, responsibility, and continuous improvement

Governance Excellence

• Enhancing quality management and risk control systems
• Maintaining transparent and compliant operations
• Aligning with global customer expectations for reliable supply partners

Through responsible manufacturing practices, CelluPro is committed to contributing to a more sustainable and resilient biopharmaceutical ecosystem.

Supporting Reliable Bioprocessing Worldwide

CelluPro believes that successful biopharmaceutical manufacturing requires more than innovative products — it requires reliable partnerships built on quality, resilience, and trust.

By integrating GMP manufacturing excellence, ISO 22301-certified business continuity management, advanced cell culture technologies, and ESG-driven operational practices, CelluPro continues to strengthen its capability to support global biopharmaceutical innovators.

Reliable Quality. Resilient Supply. Sustainable Future.

About CelluPro

CelluPro is dedicated to developing and manufacturing high-performance serum-free cell culture media solutions for global biopharmaceutical development and manufacturing.

Through advanced manufacturing technologies, internationally aligned quality systems, and comprehensive technical support, CelluPro enables customers to achieve reliable, scalable, and efficient bioprocess performance.